{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By BARRY MEIER and KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Barry", "organization": "", "lastname": "MEIER"}, {"rank": 2, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Profile of Arthur L Caplan, bioethicist appointed by Johnson & Johnson to create panel that will examine requests by desperately ill patients for experimental drugs; Caplan is not a medical doctor but has spent his entire career counseling medical professionals on thorny issues regarding ethics and morality.", "type_of_material": "News", "word_count": "911", "lead_paragraph": "Arthur Caplan, who has built a career advising doctors on difficult moral issues, will help Johnson & Johnson decide which patients receive experimental drugs.", "pub_date": "2015-05-07T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Eager to Opine on the Toughest Calls in Medical Ethics", "print_headline": "Eager to Opine on the Toughest Calls in Medical Ethics"}, "snippet": "Arthur Caplan, who has built a career advising doctors on difficult moral issues, will help Johnson & Johnson decide which patients receive experimental drugs.", "multimedia": [{"height": 126, "url": "images/2015/05/07/business/07CAPLAN/07CAPLAN-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/05/07/business/07CAPLAN/07CAPLAN-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 480, "url": "images/2015/05/07/business/07CAPLAN/07CAPLAN-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "480", "xlarge": "images/2015/05/07/business/07CAPLAN/07CAPLAN-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/05/07/business/07CAPLAN/07CAPLAN-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/05/07/business/07CAPLAN/07CAPLAN-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/05/07/business/eager-to-opine-on-the-toughest-calls-in-medical-ethics.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Caplan, Arthur L", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Johnson & Johnson", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Doctors", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "New York University Langone Medical Center", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Ethics and Official Misconduct", "name": "subject"}], "blog": [], "_id": "554ae39138f0d85a64346935", "source": "The New York Times"}